Influenza A viruses: why focusing on M2e-based universal vaccines (Q30396318)

21 June 2017

Influenza A viruses: why focusing on M2e-based universal vaccines (English)

1 reference

21 June 2017

Seyyed Mahmoud Ebrahimi

series ordinal

1

1 reference

PubMed ID

21082230

21 June 2017

Majid Tebianian

series ordinal

2

1 reference

21 June 2017

17 November 2010

1 reference

21 June 2017

1 reference

21 June 2017

42

1 reference

21 June 2017

1-8

1 reference

21 June 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s11262-010-0547-7

21 June 2017

0 references

cites work

The challenge of emerging and re-emerging infectious diseases

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Influenza: lessons from past pandemics, warnings from current incidents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Human infection with influenza H9N2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Emergence and pandemic potential of swine-origin H1N1 influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

A "universal" human influenza A vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Transmission of equine influenza virus to dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Genetics of Influenza Viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Prospects for universal influenza virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

A new European perspective of influenza pandemic planning with a particular focus on the role of mammalian cell culture vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Vaccines for seasonal and pandemic influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Changing perspective on immunization against influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Molecular changes associated with adaptation of human influenza A virus in embryonated chicken eggs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Sequences of mRNAs derived from genome RNA segment 7 of influenza virus: colinear and interrupted mRNAs code for overlapping proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Influenza virus M2 protein has ion channel activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Selective proton permeability and pH regulation of the influenza virus M2 channel expressed in mouse erythroleukaemia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Permeation and activation of the M2 ion channel of influenza A virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Evidence that the amantadine-induced, M2-mediated conversion of influenza A virus hemagglutinin to the low pH conformation occurs in an acidic trans Golgi compartment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Maturation of influenza A virus hemagglutinin--estimates of the pH encountered during transport and its regulation by the M2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

The cytoplasmic tail of the influenza A virus M2 protein plays a role in viral assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Palmitoylation of the influenza A virus M2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Distinct domains of the influenza a virus M2 protein cytoplasmic tail mediate binding to the M1 protein and facilitate infectious virus production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Influenza virus M2 integral membrane protein is a homotetramer stabilized by formation of disulfide bonds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Structural characteristics of the M2 protein of influenza A viruses: evidence that it forms a tetrameric channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Sequence comparison between the extracellular domain of M2 protein human and avian influenza A virus provides new information for bivalent influenza vaccine design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Antibody response to the M2 protein of influenza A virus expressed in insect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

The cholera toxin-derived CTA1-DD vaccine adjuvant administered intranasally does not cause inflammation or accumulate in the nervous tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Treatment of influenza virus-infected SCID mice with nonneutralizing antibodies specific for the transmembrane proteins matrix 2 and neuraminidase reduces the pulmonary virus titer but fails to clear the infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Scientific barriers to developing vaccines against avian influenza viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

An influenza A vaccine based on tetrameric ectodomain of matrix protein 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Heterologous expression, purification and characterization of the influenza A virus M2e gene fused to Mycobacterium tuberculosis HSP70(359-610) in prokaryotic system as a fusion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Protection against H1, H5, H6 and H9 influenza A infection with liposomal matrix 2 epitope vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Modified M2 proteins produce heterotypic immunity against influenza A virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

High epitope density in a single recombinant protein molecule of the extracellular domain of influenza A virus M2 protein significantly enhances protective immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Roles of CD4+ T-cell-independent and -dependent antibody responses in the control of influenza virus infection: evidence for noncognate CD4+ T-cell activities that enhance the therapeutic activity of antiviral antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Versatile virus-like particle carrier for epitope based vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

A universal influenza A vaccine based on the extracellular domain of the M2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Universal influenza A vaccine: optimization of M2-based constructs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Swine influenza matrix 2 (M2) protein contributes to protection against infection with different H1 swine influenza virus (SIV) isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

M2e-based universal influenza A vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Prokaryotic expression and characterization of avian influenza A virus M2 gene as a candidate for universal recombinant vaccine against influenza A subtypes; specially H5N1 and H9N2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0547-7

Pharmaceutical and immunological evaluation of human papillomavirus viruslike particle as an antigen carrier

21 January 2018

1 reference

12 December 2020

The distribution of positively charged residues in bacterial inner membrane proteins correlates with the trans-membrane topology

1 reference

12 December 2020

Clinical and epidemiological evaluation of a live, cold-adapted influenza vaccine for 3-14-year-olds.

1 reference

12 December 2020

N-terminus of M2 protein could induce antibodies with inhibitory activity against influenza virus replication.

1 reference

12 December 2020

Cloning, expression and purification of the influenza A (H9N2) virus M2e antigen and truncated Mycobacterium tuberculosis HSP70 as a fusion protein in Pichia pastoris

1 reference

12 December 2020

Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice

1 reference

12 December 2020

Analysis of the posttranslational modifications of the influenza virus M2 protein

1 reference

12 December 2020

Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions

1 reference

12 December 2020

Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin

1 reference

12 December 2020

10.1007/S11262-010-0547-7

Identifiers

DOI

1 reference

PubMed ID

21082230

Dimensions Publication ID

21 June 2017

0 references

1 reference

PubMed ID

21082230